Competition
Equitable Growth supports research and policy analysis on how strong competition among U.S. businesses affects inequality and broad-based economic growth. More
- Topics:
- Anticompetitive Conduct
- Antitrust Enforcement
- Concentration
Families
Equitable Growth supports research and policy analysis on how unequal access to care, 21st century work-life policies, and education undermines stable, broad-based economic growth. More
- Topics:
- Childcare & Early Education
- Economic Wellbeing
- Health
- K-12
- Post-secondary Education
Inequality & Mobility
Equitable Growth supports research and policy analysis on how trends in economic inequality and mobility and changes in the economy have affected the concentration of wealth, income, and earnings, and how these distributional shifts have affected the promise of economic security and opportunity. More
- Topics:
- Economic Inequality
- Economic Mobility
- Economics of Place
- GDP 2.0
- Gender
- Income & Earnings Volatility
- Poverty
- Race & Ethnicity
Labor
Equitable Growth supports research and policy analysis on how inequalities in wages, bargaining power, and the evolving labor market affect workers’ economic security and opportunity as well as broad-based economic growth. More
- Topics:
- AI, tech, & the economy
- Bargaining Power
- Job Mobility
- Minimum Wage
- Monopsony
- Paid Leave
- Pay Equity
- Schedule Stability
- Unemployment Insurance
- Wage Stagnation
Tax & Macroeconomics
Equitable Growth supports research and policy analysis on how tax and macroeconomic policies can promote stable and broad-based economic growth. More
- Topics:
- Business Taxation
- Climate
- Credit & Debt
- Fiscal Policy
- Individual Taxation
- Monetary Policy
- Taxes, Inequality & Growth

Washington took a decade to approve an obscure drug-pricing bill. That’s a bad omen for more ambitious reforms

Connect with us!

Explore the Equitable Growth network of experts around the country and get answers to today's most pressing questions!

Get in Touch

Connect with us

Washington took a decade to approve an obscure drug-pricing bill. That’s a bad omen for more ambitious reforms

January 7, 2020

AUTHORS:

January 7, 2020

AUTHORS:

The promise of equitable and pro-growth tax reform

U.S. economic mobility trends and outcomes